OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here. OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large,
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Frontier Medicines Corporation ("Frontier" or the "Company"), a clinical-stage precision medicine company unlocking to advance transformational therapies, today announced that Chris Varma, Ph.D., Frontier's co-founder,
Biocon shares rose 9% to ₹389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab.
Analyst revisions kept stocks of Zomato, Biocon, and ONGC in focus on Monday. While Zomato’s share price was down by 4.8% ...
Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price.
The rise in Biocon stock was also fuelled after Jefferies upgraded the stock to 'Buy', and raised the target to Rs 400 ...
Hold Biocon 320-put option as stock may drop to ₹350, with potential for premium increase. Contact [email protected] ...
Biocon Biologics had entered into a settlement and licensing agreement with Janssen Biotech Inc. and Janssen Sciences Ireland ...
Biocon’s subsidiary, Biocon Biologics Limited (BBL), has announced the completion of its first year as a fully integrated ...
Optimism for Biocon is fuelled by the green light for its Bengaluru biologics unit, paired with the USFDA approval for the launch of its Stelara biosimilar for autoimmune disorders, ...
2d
This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concerning ...
"This is to inform you that Biocon Pharma Limited, a wholly owned subsidiary of the company, has received approval for ...
Biocon's biosimilar Ustekinumab receives regulatory approval in Japan, with Yoshindo Inc. handling commercialization and ...
Biocon stock price has broken out from the upper band of a Symmetrical Triangle formation, indicating a positive movement.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback